131.06
price down icon0.68%   -0.90
after-market Dopo l'orario di chiusura: 131.06
loading
Precedente Chiudi:
$131.96
Aprire:
$131.87
Volume 24 ore:
1.46M
Relative Volume:
1.20
Capitalizzazione di mercato:
$7.39B
Reddito:
$763.34M
Utile/perdita netta:
$51.40M
Rapporto P/E:
144.28
EPS:
0.9084
Flusso di cassa netto:
$104.46M
1 W Prestazione:
-9.92%
1M Prestazione:
-10.85%
6M Prestazione:
-19.90%
1 anno Prestazione:
+7.66%
Intervallo 1D:
Value
$130.03
$133.35
Intervallo di 1 settimana:
Value
$129.00
$148.37
Portata 52W:
Value
$100.99
$175.77

Repligen Corp Stock (RGEN) Company Profile

Name
Nome
Repligen Corp
Name
Telefono
(781) 449-9560
Name
Indirizzo
41 SEYON STREET, WALTHAM, MA
Name
Dipendente
2,000
Name
Cinguettio
@repligen
Name
Prossima data di guadagno
2026-07-28
Name
Ultimi documenti SEC
Name
RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, MDLN, ALC, RMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RGEN icon
RGEN
Repligen Corp
131.06 7.44B 763.34M 51.40M 104.46M 0.9084
ISRG icon
ISRG
Intuitive Surgical Inc
356.83 120.92B 11.03B 3.16B 3.22B 8.7251
BDX icon
BDX
Becton Dickinson Co
158.92 43.08B 21.37B 1.41B 3.07B 3.9437
MDLN icon
MDLN
Medline Inc
39.70 32.77B 29.14B 1.07B 1.05B 1.1956
ALC icon
ALC
Alcon Inc
67.28 33.12B 10.63B 819.00M 1.59B 1.6577
RMD icon
RMD
Resmed Inc
203.08 28.33B 5.54B 1.52B 1.74B 10.37

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-04-17 Iniziato Rothschild & Co Redburn Buy
2025-10-01 Iniziato HSBC Securities Buy
2025-09-22 Aggiornamento Evercore ISI In-line → Outperform
2025-07-22 Ripresa Stephens Overweight
2025-06-24 Iniziato Barclays Overweight
2025-04-29 Aggiornamento Wolfe Research Peer Perform → Outperform
2025-03-18 Iniziato Evercore ISI In-line
2025-02-10 Iniziato TD Cowen Buy
2024-12-17 Iniziato Canaccord Genuity Hold
2024-11-14 Iniziato Wolfe Research Peer Perform
2024-08-28 Iniziato Wells Fargo Overweight
2024-06-26 Aggiornamento Deutsche Bank Hold → Buy
2024-06-18 Iniziato Guggenheim Neutral
2023-12-04 Downgrade The Benchmark Company Buy → Hold
2023-07-20 Iniziato Wells Fargo Overweight
2023-07-05 Ripresa JP Morgan Overweight
2023-03-28 Iniziato The Benchmark Company Buy
2022-12-14 Iniziato Deutsche Bank Hold
2022-12-07 Iniziato RBC Capital Mkts Sector Perform
2022-07-20 Iniziato UBS Buy
2021-10-14 Iniziato Exane BNP Paribas Outperform
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-30 Reiterato H.C. Wainwright Buy
2020-05-07 Reiterato H.C. Wainwright Buy
2020-03-23 Reiterato H.C. Wainwright Buy
2019-11-15 Iniziato Stifel Buy
2019-11-01 Aggiornamento First Analysis Sec Outperform → Strong Buy
2019-10-15 Iniziato SVB Leerink Outperform
2019-08-28 Reiterato First Analysis Sec Outperform
2019-08-23 Ripresa Stephens Overweight
2019-07-22 Aggiornamento H.C. Wainwright Neutral → Buy
2018-12-17 Aggiornamento CL King Neutral → Buy
2018-11-12 Downgrade CL King Buy → Neutral
2018-09-26 Iniziato H.C. Wainwright Neutral
2017-12-08 Iniziato Citigroup Buy
2017-12-05 Iniziato JP Morgan Overweight
2017-11-13 Iniziato CL King Buy
2017-10-02 Aggiornamento First Analysis Sec Equal-Weight → Overweight
2017-07-21 Iniziato William Blair Outperform
2017-02-13 Aggiornamento Piper Jaffray Neutral → Overweight
Mostra tutto

Repligen Corp Borsa (RGEN) Ultime notizie

pulisher
03:59 AM

RGEN|Repligen Corp|Price:131.960|Chg%:-5.640 - TradingKey

03:59 AM
pulisher
03:17 AM

Repligen (RGEN) Q2 Earnings: What To Expect - Yahoo! Finance Canada

03:17 AM
pulisher
01:24 AM

ETFs Investing in Repligen Corporation Stocks - TradingView

01:24 AM
pulisher
12:04 PM

Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

12:04 PM
pulisher
Jul 26, 2026

Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK

Jul 25, 2026
pulisher
Jul 24, 2026

Repligen Corp (RGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen Corp|Price:131.970|Chg%:-5.630 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

RGEN|Repligen Corp|Price:130.951|Chg%:-1.009 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen’s $1.5 Billion Acquisition Could Reshape Its Growth Story! - Smartkarma

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Daily Brief Health Care: Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Akeso, Mitesco Inc, Nagaileben, Repligen Corp, Scribe Therapeutics, Cosmos Health and more - Smartkarma

Jul 24, 2026
pulisher
Jul 24, 2026

Is Repligen Corp (RGEN) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan

Jul 24, 2026
pulisher
Jul 24, 2026

Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - Zacks Investment Research

Jul 23, 2026
pulisher
Jul 23, 2026

Canaccord reiterates Hold on Repligen stock after BioLife deal By Investing.com - Investing.com India

Jul 23, 2026
pulisher
Jul 23, 2026

RGEN stock holds steady as Repligen backs 2026 growth - Ad-hoc-news.de

Jul 23, 2026
pulisher
Jul 23, 2026

Canaccord reiterates Hold on Repligen stock after BioLife deal - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals

Jul 23, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Leadership in Cell Therapy Market - Minichart

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire Bothell's BioLife Solutions in $1.5B Deal - 425business.com

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-stock deal - Stock Titan

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions for $11.25 per Share Plus Stock, Enhancing Cell Processing Capabilities - Kalkine Media

Jul 22, 2026
pulisher
Jul 22, 2026

US759916AC3 Bond Profile — Key Metrics - TradingView

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Yahoo Finance

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business - ETPharma.com

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen targets cell therapy expansion as Waltham firm inks $1.5 billion acquisition - The Business Journals

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal, Expanding Into Cell Therapy - finance.biggo.com

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife - Reuters

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen Announces Acquisition of BioLife Solutions in $11.25 Per Share Cash and Stock Deal - Kalkine Media

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions in Cash and Stock Merger Valued at $11.25 Per Share - Kalkine Media

Jul 22, 2026
pulisher
Jul 22, 2026

What's Going on With Repligen Stock Wednesday?Repligen (NASDAQ:RGEN), BioLife Solutions (NASDAQ:BLFS) - Benzinga

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen Corporation (Nasdaq: RGEN) sets cash–stock deal to buy BioLife - Stock Titan

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions in Cash-and-Stock Deal; $11.25 Plus 0.1442 Shares Per Share - TradingView

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen Corp: If Deal Terminated Under Some - Moomoo

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to Acquire BioLife Solutions in $1.5 Billion Deal - sekbernews.id

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen Corp To Acquire BioLife Solutions Transcript - GuruFocus

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to buy cell therapy maker BioLife in $1.5 billion deal - MSN

Jul 22, 2026
pulisher
Jul 22, 2026

Repligen to acquire BioLife Solutions for $1.5 billion - Investing.com

Jul 22, 2026
pulisher
Jul 22, 2026

BioLife’s Biopreservation Media Supports 18 Commercially Approved Therapies - Stock Titan

Jul 22, 2026
pulisher
Jul 21, 2026

A Look at Repligen Corp (RGEN) After 5.9% Decline -- GF Value $1 - GuruFocus

Jul 21, 2026
pulisher
Jul 21, 2026

Why Repligen (RGEN) Stock Is Trading Lower Today - Yahoo Finance

Jul 21, 2026
pulisher
Jul 21, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Jul 21, 2026
pulisher
Jul 21, 2026

Repligen to buy BioLife Solutions (NASDAQ: BLFS) in cash and stock merger - Stock Titan

Jul 21, 2026
pulisher
Jul 18, 2026

Form 4 Repligen Corporation For: 17 July By Investing.com - Investing.com South Africa

Jul 18, 2026
pulisher
Jul 18, 2026

Repligen CFO Jason K Garland sells $79,500 in stock - Investing.com UK

Jul 18, 2026
pulisher
Jul 17, 2026

Repligen CFO Jason K Garland sells $79,500 in stock By Investing.com - Investing.com Nigeria

Jul 17, 2026
pulisher
Jul 17, 2026

Repligen CFO Jason Garland Sells 530 Shares Under Pre-Arranged Rule 10b5-1 Trading Plan - Kalkine Media

Jul 17, 2026

Repligen Corp Azioni (RGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$168.05
price up icon 0.62%
BAX BAX
$23.34
price up icon 4.20%
COO COO
$70.29
price down icon 0.03%
$80.47
price up icon 3.15%
WST WST
$331.25
price up icon 0.93%
RMD RMD
$203.08
price up icon 4.00%
Capitalizzazione:     |  Volume (24 ore):